Carlos Caulı́n
ORCID: 0000-0002-5059-0016Also affiliated with Arizona Oncology, University of Arizona Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).”.
Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia +14 more
Tongxin Xie, Thomas J. Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou +6 more
Tongxin Xie, Thomas J. Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou +6 more
Vicente Escamilla-River, Stephanie L Tribble, Carlos Caulı́n, Justin E. Wilson, Dakota M. Reinartz
Vicente Escamilla‐Rivera, Manlin Shao, Stephanie L Tribble, Carlos Caulı́n, Justin E. Wilson +1 more